Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $85 Price Target
Benzinga Newsdesk 9 months ago
NewsPrice TargetAnalyst Ratings
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintains $85 price target.
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintains $85 price target.